TAMPA, Fla., Feb. 23, 2005 (PRIMEZONE) -- 66-year old physician and surgeon Dr. Allan N. Fields presented his recommendations to the FDA advisory panel last Thursday, stating, "I have been advising my patients to minimize the use of oral prescription and OTC medications, and to instead use O24, which does no harm to the human body." Swiss Medica's (OTCBB:SWME) President Grant Johnson also spoke and presented the FDA panelists with summaries of three European medical studies, a U.S.-based open trial, and a recently concluded Canadian randomized double-blind clinical trial, using the O24(tm) Essential Oil Pain Neutralizer. Dr. Fields announced to the medical and scientific panelists that his "Patients have been using less of the aforementioned drugs and saving money in the process. No serious adverse effects, such as GI bleed, hypertension or cardiovascular problems have ever been reported." Dr. Fields advised the panel members, "There is no interference with other medications that are necessary to maintain the patient's health." Because many panelists were also medical doctors, the surgeon reminded them, "As physicians we have taken an oath to provide the most effective care while not knowingly harming the patient."
A photo accompanying this release is available at: http://www.primezone.com/newsroom/prs/?pkgid=1433
A recent StockInterview.com article recaps the three-day Gaithersburg, Maryland joint FDA advisory committees meetings, offering greater depth and insights than provided in many of the mainstream articles posted in daily newspapers and on conventional news services.
The entire article appears on StockInterview.com: www.stockinterview.com/swiss-medica-fda-advisory-panel.html
The U.S.-patented non-toxic, non-addictive O24 pain relief formula has been popular among athletes over the past decade and is being widely introduced in nationally recognized U.S. pharmacies during the first half of 2005.
The Swiss Medica logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1375
